Document is current
Any future updates will be listed below
-
Authors
Zhuo, Duan
Lei, Zhenchuan
Dong, Lin
Chan, Andrew Man Lok
Lin, Jiacheng
Jiang, Liwen
Qiu, Beibei
Jiang, Xiaohua
Tan, Youhua
Yao, Xiaoqiang http://orcid.org/0000-0002-0687-8186
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 4 August 2024
First Online: 13 August 2024
Declarations
:
: Animals were supplied by the University Laboratory Animal Services Centre, and all animal studies were approved by the Animal Experimental Ethics Committee of The Chinese University of Hong Kong. The approved project title: Role of Ca<sup>2+</sup>-permeable channels Orai1 and Orai3 in breast cancer stem cells. Approval number: 20-264-GRF. The date of approval: June 28, 2021. For the patients’ samples, the patients or their guardians/legally authorized representatives provided written informed consent for participation in the study and the use of samples. The immunohistochemical experiments using human tissue samples were approved by Ethics Committee of Feicheng Hospital Affiliated to Shangdong First Medical University. The title of the approved project title: Orai1 and Orai3 act through distinct signalling axes to promote stemness and tumorigenicity of breast cancer stem cells. Approval number: 20211001. The date of approval: August 20, 2021.
: All authors confirm their consent for publication.
: The authors declare no competing interests.
